Delivering a smoke-free future

Our current product portfolio primarily consists of cigarettes and smoke-free products, including heated tobacco, e-vapor, and oral smokeless products.

As of June 30, 2024,  38 percent of our total net revenues came from our smoke-free products.

By 2030, our ambition is to increase that figure to over two-thirds, with the ultimate goal of phasing out cigarettes completely. Leveraging our scientific expertise and technological capabilities, we are also committed to developing new products in the wellness and healthcare space.

grey box

Looking to invest in a smoke-free future?

See the latest public disclosures and other investor information for Philip Morris International.

Find out more
grey box

Press releases & events

See more

 

grey box

Stock, dividends and bonds

See more
IQOS ILUMA heated tobacco product

We're evolving our portfolio to include products beyond tobacco and nicotine.


 

We're evolving our portfolio to include products beyond tobacco and nicotine.


 

grey box

Our smoke-free products

At PMI, it is our ambition to replace cigarettes with science-based smoke-free products as soon as possible.

Find out more
preventing youth use of our products thumbnail

Preventing youth use of our products

Learn more

 

Lausanne hallway thumbnail

Suppliers

Find out more

Subscribe to our newsletter

Sign up for all the latest news and views

FAQs

From company information and sustainability to careers and our smoke-free portfolio, we answer frequently asked questions.


IQOS ILUMA heated tobacco product

Heated tobacco products FAQs

Find out more
VEEV ONE e-vapor device by Philip Morris International

E-vapor products FAQs

Find out more

 

Group of friends talking

Oral smokeless products FAQs

Find out more